title: Aberrations in chromosomes associated with lymphoma and therapy-related leukemia in benzene-exposed workers.
abstract: Epidemiological studies show that benzene exposure is associated with an increased incidence of leukemia and perhaps lymphoma. Chromosomal rearrangements are common in these hematopoietic diseases. Translocation t(14;18), the long-arm deletion of chromosome 6 [del(6q)], and trisomy 12 are frequently observed in lymphoma patients. Rearrangements of the MLL gene located on chromosome 11q23, such as t(4;11) and t(6;11), are common in therapy-related leukemias resulting from treatment with topoisomerase II inhibiting drugs. To examine numerical and structural changes in these chromosomes (2, 4, 6, 11, 12, 14, and 18), fluorescence in situ hybridization (FISH) was employed on metaphase spreads from workers exposed to benzene (n = 43) and matched controls (n = 44) from Shanghai, China. Aneuploidy (both monosomy and trisomy) of all seven chromosomes was increased by benzene exposure. Benzene also induced del(6q) in a dose-dependent manner (P(trend) = 0.0002). Interestingly, translocations between chromosomes 14 and 18, t(14;18), known to be associated with follicular non-Hodgkin lymphoma, were increased in the highly exposed workers (P < 0.001). On the other hand, translocations between chromosome 11 and other partner chromosomes that are found in therapy-induced leukemias were not increased. These data add weight to the notion that benzene can induce t(14;18) and del(6q) found in lymphoma, but do not support the idea that benzene induces t(4;11) or t(6;11). However, they do not rule out the possibility that other rearrangements of the MLL gene at chromosome 11q23 may be induced by benzene.
authors.affiliation: School of Public Health, University of California, Berkeley, California, USA. luoping@berkeley.edu
authors.forename: Luoping
authors.initials: L
authors.lastname: Zhang
authors.forename: Nathaniel
authors.initials: N
authors.lastname: Rothman
authors.forename: Guilan
authors.initials: G
authors.lastname: Li
authors.forename: Weihong
authors.initials: W
authors.lastname: Guo
authors.forename: Wei
authors.initials: W
authors.lastname: Yang
authors.forename: Alan E
authors.initials: AE
authors.lastname: Hubbard
authors.forename: Richard B
authors.initials: RB
authors.lastname: Hayes
authors.forename: Songnian
authors.initials: S
authors.lastname: Yin
authors.forename: Wei
authors.initials: W
authors.lastname: Lu
authors.forename: Martyn T
authors.initials: MT
authors.lastname: Smith
mesh_terms: D000328:Adult; D001554:Benzene / Q000008:administration & dosage*; D016022:Case-Control Studies; D002869:Chromosome Aberrations; D002872:Chromosome Deletion; D002877:Chromosomes, Human / Q000235:genetics; D005260:Female; D006801:Humans; D007221:Industry; D007938:Leukemia / Q000235:genetics*; D008223:Lymphoma / Q000235:genetics*; D008297:Male; D009006:Monosomy; D016609:Neoplasms, Second Primary / Q000235:genetics*; D016273:Occupational Exposure; D014178:Translocation, Genetic; D000078329:Workforce
chemical_list: D001554:Benzene